Vestor Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$640K Hold
1,646
– – 0.04% 97
2026
Q2
$637K Hold
1,646
– – 0.04% 110
2026
Q1
$482K Hold
1,646
– – 0.03% 105
2025
Q4
$577K Sell
1,646
-700
-30% -$237K 0.04% 88
2025
Q3
$758K Hold
2,346
– – 0.05% 98
2025
Q2
$913K Hold
2,346
– – 0.07% 88
2025
Q1
$1.02M Sell
2,346
-4
-0.2% -$1.61K 0.08% 87
2024
Q4
$867K Buy
2,350
+4
+0.2% +$1.67K 0.07% 104
2024
Q3
$1.22M Buy
2,346
+650
+38% +$347K 0.1% 72
2024
Q2
$919K Buy
1,696
+540
+47% +$285K 0.07% 79
2024
Q1
$599K Sell
1,156
-6
-0.5% -$2.98K 0.05% 101
2023
Q4
$548K Hold
1,162
– – 0.05% 96
2023
Q3
$506K Sell
1,162
-92
-7% -$41.7K 0.05% 98
2023
Q2
$557K Sell
1,254
-22,972
-95% -$10.6M 0.06% 94
2023
Q1
$11.1M Sell
24,226
-81
-0.3% -$38.5K 1.31% 23
2022
Q4
$12.5M Sell
24,307
-249
-1% -$126K 1.5% 22
2022
Q3
$11.2M Sell
24,556
-1,448
-6% -$693K 1.46% 22
2022
Q2
$12.5M Buy
26,004
+24,779
+2,023% +$12.3M 1.52% 25
2022
Q1
$602K Hold
1,225
– – 0.06% 90
2021
Q4
$568K Hold
1,225
– – 0.05% 88
2021
Q3
$457K Buy
+1,225
New +$466K 0.05% 97

Other funds holding ELV

Vestor Capital's ELV Position: Q3 2026 in Review

Vestor Capital held its Elevance Health (ELV) position steady in Q3 2026 at 1,646 shares worth $640K. The position accounts for 0.04% of the portfolio, ranked #97.

Vestor Capital first reported a position in ELV in Q3 2021 and has held it in 21 quarters since. The position peaked at $12.5M in Q2 2022. 1,627 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Vestor Capital held 1,646 shares of Elevance Health worth $640K as of Q3 2026.
  • Vestor Capital left its Elevance Health share count unchanged in Q3 2026.
  • Elevance Health made up 0.04% of Vestor Capital's portfolio in Q3 2026, its #97 holding.
  • Vestor Capital first reported a position in Elevance Health in Q3 2021 and has held it in 21 quarters since.
  • Vestor Capital's Elevance Health position peaked at $12.5M in Q2 2022.
  • 1,627 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Vestor Capital's 13F filing for Q3 2026, filed 3 Nov 2026.